Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians
Launched by MAYO CLINIC · Jul 29, 2009
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Peri and Postmenopausal Caucasian, Black, Hispanic and Asian women, aged 50-90
- • Bone mineral density (BMD) T-Score \< 1.0
- • Have appointment with clinician to discuss test results and treatment options
- • Patients with FRAX \<20% risk who have taken a bisphosphonate for \< 5 years.
- Exclusion Criteria:
- • Unable to speak or read English
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Victor M. Montori, M.D.
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials